H. Arikan Et Al. , "Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients," RENAL FAILURE , vol.29, no.6, pp.713-719, 2007
Arikan, H. Et Al. 2007. Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients. RENAL FAILURE , vol.29, no.6 , 713-719.
Arikan, H., Koc, M., Sari, H., Tuglular, S., Ozener, C., & Akoglu, E., (2007). Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients. RENAL FAILURE , vol.29, no.6, 713-719.
Arikan, İZZET Et Al. "Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients," RENAL FAILURE , vol.29, no.6, 713-719, 2007
Arikan, İZZET H. Et Al. "Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients." RENAL FAILURE , vol.29, no.6, pp.713-719, 2007
Arikan, H. Et Al. (2007) . "Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients." RENAL FAILURE , vol.29, no.6, pp.713-719.
@article{article, author={İZZET HAKKI ARIKAN Et Al. }, title={Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients}, journal={RENAL FAILURE}, year=2007, pages={713-719} }